688373.SS · 盟科药业
China A-shares · RS rating 47 · As of 2026-10-14
| Price | 5.27 CNY |
|---|---|
| 1-day change | -3.8% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 47 / 64 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 10 / 8 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +12.9% |
| Distance from 52-week high | +45.7% |
| Market cap (USD) | $545.7M |